%0 Journal Article
%T Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis
%A Alyn H. Morice
%A Dejene Shiferaw
%A Shoaib Faruqi
%J Archive of "The Open Respiratory Medicine Journal".
%D 2016
%R 10.2174/1874306401610010105
%X Cough is a major symptom in cystic fibrosis. Ivacaftor is a novel drug which targets the G551D mutation and has been demonstrated to improve lung function and weight in the long term. It also improves symptoms of extra-oesophageal reflux. We wanted to evaluate the effect of ivacaftor on cough in cystic fibrosis
%K Cystic fibrosis
%K Cough
%K Ivacaftor
%K Gastro-oesophageal reflux
%K G551D mutation
%K Lung function
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299558/